Table 2:
Systemic Conditions | Endocrine | Endogenous | Hypoparathyroidism |
Addison Disease | |||
Exogenous | Human Growth Hormone | ||
Thyroxine | |||
Leuprolin acetate | |||
Anabolic steroids | |||
Withdrawal of chronic steroids | |||
Metabolic | Hypervitaminosis A | ||
Anemia | Anemia | ||
Leukemia | |||
Coagulation Disorders | |||
Renal Failure/ Uremia | |||
Autoimmune | SLE | ||
Behcets | |||
Hypercapnea | Sleep apnea | ||
Pickwickian syndrome | |||
Genetic Conditions | Turner syndrome | ||
Trisomy 21 | |||
Medications | Antibiotics | Tetracyclines (minocycline, doxycycline) | |
Nalidixic Acid | |||
Sulfa drugs | |||
Fluoroquinolones | |||
Nitrofurantoin | |||
Lithium | |||
Chlordecone | |||
Vitamin A derivatives | Isoretinoin | ||
Trans-retinoic acids | |||
Cerebral venous abnormalities | CSVT | ||
SVC syndrome | |||
AV fistulas | |||
Decreased CSF absorption from previous intracranial infection or SAH | |||
Hypercoagulable state | |||
Increased right heart pressure | |||
Middle ear or mastoid infection | |||
Bilateral jugular venous thrombosis or surgical ligation |